HC Surgical Specialists Limited
Research HC Surgical Specialists Limited (1B1.SI) on Bullrun: market cap SGD 55.98M, P/E 7.3, dividend yield 5.7%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker1B1.SI
- ExchangeSGX
- CountrySingapore
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencySGD
- Market capSGD 55.98M
- P/E7.3
- Dividend yield5.7%
Valuation Snapshot
latest market cap is SGD 55.98M; P/E is 7.3; dividend yield is 5.7%.
Peer valuation comparison
Latest P/E is 7.3x versus a Healthcare sector median of 21.74x (66.4% below).
Latest dividend yield is 5.7% versus a Healthcare sector median of 2.4% (137.5% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | SGD 19.11M | SGD 8.44M | SGD 6.75M | 84.3% | 0.05 | SGD 5.09M | SGD 2.78M | SGD 20.95M |
| FY2024 | SGD 18.81M | SGD 3.85M | SGD 6.23M | 84.9% | 0.03 | SGD 7.36M | SGD 4.34M | SGD 14.69M |
| FY2023 | SGD 19.08M | SGD 2.92M | SGD 6.51M | 86.2% | 0.02 | SGD 6.19M | SGD 5.50M | SGD 12.10M |
| FY2022 | SGD 19.31M | SGD 6.38M | SGD 6.84M | 86.3% | 0.04 | SGD 6.93M | SGD 6.25M | SGD 11.00M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-17 | SGD 55.98M | 7.3 | 6.5% | 0.02 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.02 SGD, yield 5.7%.
| Year | Dividends/share |
|---|---|
| FY2026 | 0.01 SGD |
| FY2025 | 0.02 SGD |
| FY2024 | 0.01 SGD |
| FY2023 | 0.02 SGD |
| FY2022 | 0.03 SGD |
About HC Surgical Specialists Limited
HC Surgical Specialists Limited, an investment holding company, provides medical services primarily in Singapore. The company provides endoscopic procedures, including gastroscopies and colonoscopies; and general surgery services with a focus on colorectal procedures in a network of clinics.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is HC Surgical Specialists Limited's market cap?
HC Surgical Specialists Limited's market capitalization is SGD 55.98M.
What is HC Surgical Specialists Limited's P/E ratio?
HC Surgical Specialists Limited's price-to-earnings (P/E) ratio is 7.3.
Does HC Surgical Specialists Limited pay a dividend?
HC Surgical Specialists Limited has a dividend yield of 5.7%.
What does HC Surgical Specialists Limited do?
HC Surgical Specialists Limited, an investment holding company, provides medical services primarily in Singapore. The company provides endoscopic procedures, including gastroscopies and colonoscopies; and general surgery services with a focus on colorectal procedures in a network of clinics. It also offers treatment services for other conditions, such as haemorrhoids, anal fissure, hernia, anal abscess, cholecystitis, anal fistula, appendicitis, colorectal cancer, lipomas, cysts, and gastric cancer, vein laser vascular, laparoscopy, and other general and specialized medical services.